A Study of the Safety and Efficacy of Bimatoprost Ophthalmic Solution in Paediatric Patients With Glaucoma

The purpose of this study is to assess the safety and efficacy of a new formulation of bimatoprost ophthalmic solution compared to timolol ophthalmic solution in the treatment of paediatric patients with glaucoma.

Inclusion Criteria:

• Diagnosis of congenital, juvenile glaucoma
• Requires treatment with IOP-lowering medication in one or both eyes

Exclusion Criteria:

• Surgical intervention is indicated or planned to lower IOP
• Abnormally low body weight (below 5th percentile)
• Any active eye infection or disease
• Anticipated use of contact lenses during the study
• Topical ocular steroid use within 2 months
• History of ocular trauma in either eye
• Required chronic use of ocular medications (other than study medication) during the study (intermittent use of artificial tears permitted)